Rare Eosinophilic Disease Part 2 – Diagnostic Challenges & the Role of the ENT

Are you missing rare eosinophilic disease diagnoses? Join an expert multidisciplinary panel for a podcast series highlighting the diagnostic challenges of eosinophilic granulomatosis with polyangiitis (EGPA; formerly Churg-Strauss) and what the otolaryngologist needs to know. Moderated by Dr. Jennifer Villwock. Rare Eosinophilic Disease Part 2 – Diagnostic Challenges & the Role of the ENT Listen to 2 expert otolaryngologists, Drs. Michael Platt and Ashoke Khanwalkar, in conjunction with their pulmonologist (Dr. Praveen Akuthota) and rheumatologist (Dr. Anisha Dua) colleagues, review the nuances of the ENT presentation in patients with EGPA including diagnostic tests, the role of biopsy and tips around referrals. Listen to Part 1 This is a non-CME disease state educational podcast series brought to you by the AAOA and sponsored by GSK. The information presented is scientific and non-promotional in nature. The panelists are practicing physicians paid by GSK to share their knowledge and expertise. Trademarks are owned by or licensed to the GSK group of companies.©2024 GSK group of companies or its licensor.

Om Podcasten

The Resource for ENT Allergists Note: The views, information, or opinions expressed during the AAOA podcast series are solely those of the individuals involved and do not necessarily represent those of The American Academy of Otolaryngic Allergy (AAOA) or its employees or members. The AAOA is not responsible and does not verify for accuracy any of the information contained in and assumes no liability for any activities in connection with this podcast series. The primary purpose of this podcast series is to educate and inform and does not constitute medical or other professional advice or services. Advertising which is incorporated into, placed in associate with, or targeted toward the content of this product, without express approval and acknowledgment of the AAOA, is forbidden. This podcast is available for private, non-commercial use only and may not be edited or modified from its original form or reproduced for distribution.